The novel transcriptomic signature of angiogenesis predicts clinical outcome, tumor microenvironment and treatment response for prostate adenocarcinoma

Table 3 The multivariate Cox regression analysis for the ARGs signature and clinical features

Index	Hazar ratio	95%CI	p-value
ARGs signature score	2.88	2.07–4.00	< 0.001
Age	1.00	0.97–1.00	0.820
PSA	1.02	0.98–1.10	0.335
Gleason score primary + secondary	1.54	1.14–2.10	0.005
T stage	1.78	1.27–2.50	0.001
N stage	0.73	0.41–1.30	0.293

ISSN: 1528-3658